Riders on the storm: VenatoRx bags a $42M round to back antibiotics pipeline
The small group of experienced biotech vets that started VenatoRx took their time getting the lead antibiotic program into the clinic. But after getting rolling …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
